Key facts
- Neptune Medical’s last known valuation is $387.0M.
- It has raised $190.5M; the latest was Later Stage VC ($97.0M) in Aug 2024.
- Notable investors include InterVest, Johnson & Johnson JJDC, LB Investment, ShangBay Capital, Invus Opportunities — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Neptune Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Neptune Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Neptune Medical
Developer of a novel gastroenterology device designed to assist in diagnosing and treating small intestine diseases. The company's device offers tip control in any anatomy, allowing the endoscope scope tip to move forward and torque as needed, and remain in place with an open lumen to swap or reinsert scopes without kinks and luminal collapse, enabling doctors to speed up procedures, reduce anesthesia time, and improve patient comfort.
- Sector
- Healthcare
- HQ
- Burlingame, CA, United States
- Founded
- 2014
- Employees
- 143
- Website
- gipathfinder.com/
- Ownership
- Privately Held (backing)
Neptune Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Neptune Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Neptune Medical in its N-PORT filings yet. We sweep new filings monthly.